Loading...
Spencer Pharmaceutical Inc.
SPPH•PNK
Healthcare
Medical - Pharmaceuticals
$0.00
$0.00(0.00%)
Spencer Pharmaceutical Inc. (SPPH) Company Profile & Overview
Explore Spencer Pharmaceutical Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Spencer Pharmaceutical Inc. (SPPH) Company Profile & Overview
Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, Massachusetts.
SectorHealthcare
IndustryMedical - Pharmaceuticals
CEOMaximilien Arella
Contact Information
8 Faneuil Hall Marketplace, Boston
Company Facts
IPO DateFeb 7, 2023
CountryUS
Actively Trading